• About
  • Reports
  • Data
  • Consulting Services
  • Insights
  • Cart
MDDetails
  • About
  • Reports
  • Data
  • Consulting Services
  • Insights
  • Cart

MDDetails > Downloads

  • Xalkori 2014 report

    FIND ANOTHER REPORT...

    MDDetails

  • Xarelto 2014 report

    FIND ANOTHER REPORT...

    MDDetails

  • Xartemis XR 2014 report

    FIND ANOTHER REPORT...

    MDDetails

  • Xeljanz 2014 report

    FIND ANOTHER REPORT...

    MDDetails

  • Xenazine 2014 report

    FIND ANOTHER REPORT...

    MDDetails

  • Xeomin 2014 report

    FIND ANOTHER REPORT...

    MDDetails

  • Xgeva 2014 report

    FIND ANOTHER REPORT...

    MDDetails

  • Xiaflex 2014 report

    FIND ANOTHER REPORT...

    MDDetails

  • Xifaxan 2014 report

    FIND ANOTHER REPORT...

    MDDetails

  • Xofigo 2014 report

    FIND ANOTHER REPORT...

    MDDetails

  • Xolair 2014 report

    FIND ANOTHER REPORT...

    MDDetails

  • Xtandi 2014 report

    FIND ANOTHER REPORT...

    MDDetails
  • Previous
  • 1
  • ...
  • 458
  • 459
  • 460
  • 461
  • 462
  • ...
  • 463
  • Next

Recent Posts

  • Five Contemporary Drug Launch Phenotypes​ Every Pharma Marketer Should Know
  • Industry-Sponsored Speaking Tracker
  • U.S. Sales Force Estimator
  • Lilly’s endocrinology-centric launch of Trulicity into T2D
  • Target specialty mix in prostate cancer: Urology vs. Oncology

Categories

  • Case Study
  • Launch Benchmarking
  • Opinion Leader Mapping
  • Product Promotion
  • Tool

©[the-year] MDDetails · Built in Boston, MA

  • @MD_Details
  • Contact Us